Dexmedetomidine Efficacy in Sepsis: A Meta-Analysis of RCTs
by Lin Chen·Updated 3mo ago
6.5 MB8files
Available on 2 platforms
Sign in to view source links and access this dataset
Description
A meta-analysis of 15 randomized controlled trials evaluates the efficacy and safety of dexmedetomidine (DEX) compared to other sedatives in 3,882 mechanically ventilated patients with sepsis and septic shock. The analysis found DEX significantly reduced the duration of mechanical ventilation but increased the risk of bradycardia, with no significant differences observed in mortality, SOFA scores, ICU length of stay, or hypotension incidence. The dataset likely contains aggregated statistical results from the systematic review, including risk ratios, mean differences, confidence intervals, and heterogeneity metrics.
Use Cases
Comparing mortality and organ failure outcomes between sedatives based on aggregated risk ratios and SOFA score differences.
Assessing the trade-off between reduced ventilation time and adverse events like bradycardia using reported mean differences and risk ratios.
Informing systematic review methodologies by examining the search strategy covering PubMed, Embase, Scopus, and Cochrane Library up to May 2025.
Evaluating heterogeneity in treatment effects across studies using reported I² statistics for outcomes like ICU length of stay.
Strengths
The analysis is based on a substantial patient population of 3,882 individuals from 15 randomized controlled trials.
Clear, pre-specified primary and secondary outcomes (mortality, SOFA scores, ventilation duration, etc.) with reported statistical metrics (RR, MD, CI, I²).
Data is openly shared under a permissive CC-BY-4.0 license, facilitating reuse and verification.
Limitations
The dataset's specific column structure and raw data rows are not described, limiting detailed reproducibility.
The file size (6.8 MB) and format (DOCX, TIF) suggest the primary content may be a document and figures rather than a structured data table.
No information is provided on the individual study characteristics, patient demographics, or dosing regimens included in the meta-analysis.
Provenance
Source
Systematic search of PubMed, Embase, Scopus, and Cochrane Library from inception through May 1, 2025.
Collection Method
Meta-analysis of randomized controlled trials.
Time Range
Studies from database inception through May 1, 2025.
Freshness
Last updated on 2026-03-18.
Primary data appears to be the results of a statistical meta-analysis, not individual patient-level data. The main files are document (DOCX) and image (TIF) formats.